August 24, 2014 | Israeli biotechnology company NeuroDerm raised $16 million in investments to continue working on its wearable treatment for Parkinson’s disease. The financing round was led by existing investors. The company is currently in the midst of a mid-stage study for its treatment for neurodegenerative disease, a belt pump that is worn around the waist and continuously administers Parkinson’s drugs for the most severe cases. The company and the testing of their Phase II treatment received a $1 million from the Michael J. Fox Foundation for Parkinson’s Research.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

AI Startup Helps Doctors Analyze Heart Scans
February 08, 2023

AI Monitors High-Speed Conveyor Belts For Defects
February 08, 2023

Israel Hi-Tech Group In Rescue Mission To Turkey
February 08, 2023

Israeli Startup Tests Cancer Treatment With Pharma Giant
February 07, 2023
Facebook comments